These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 11686016)

  • 1. The evolving role of endocrine therapy for treatment and prevention of breast cancer.
    Gradishar WJ; Jordan VC
    Cancer Chemother Biol Response Modif; 2001; 19():215-36. PubMed ID: 11686016
    [No Abstract]   [Full Text] [Related]  

  • 2. Elderly breast cancer patients: adjuvant chemotherapy and adjuvant endocrine therapy.
    Biganzoli L; Aapro M
    Gynakol Geburtshilfliche Rundsch; 2005 Jun; 45(3):137-42. PubMed ID: 15990438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evolving role of endocrine therapy for the treatment and prevention of breast cancer.
    Gradishar WJ; Jordan VC
    Cancer Chemother Biol Response Modif; 2002; 20():227-38. PubMed ID: 12703207
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant chemotherapy and hormonal therapy for older adults with breast cancer.
    Hurria A
    Semin Oncol; 2008 Dec; 35(6):618-24. PubMed ID: 19027465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Landmark trials in endocrine adjuvant therapy for breast carcinoma.
    Gradishar W
    Cancer; 2006 Mar; 106(5):975-81. PubMed ID: 16435388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant endocrine therapy for premenopausal women with early breast cancer.
    Dellapasqua S; Colleoni M; Gelber RD; Goldhirsch A
    J Clin Oncol; 2005 Mar; 23(8):1736-50. PubMed ID: 15755982
    [No Abstract]   [Full Text] [Related]  

  • 7. [First drug for prevention of breast cancer].
    MMW Fortschr Med; 1999 Aug; 141(34):16. PubMed ID: 10766546
    [No Abstract]   [Full Text] [Related]  

  • 8. Defining the role of aromatase inhibitors in the adjuvant endocrine treatment of early breast cancer.
    Buzdar A; Chlebowski R; Cuzick J; Duffy S; Forbes J; Jonat W; Ravdin P
    Curr Med Res Opin; 2006 Aug; 22(8):1575-85. PubMed ID: 16870082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
    Mariotto AB; Feuer EJ; Harlan LC; Abrams J
    J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Additional effect of SERM: mammary gland].
    Kurebayashi J
    Clin Calcium; 2004 Oct; 14(10):47-51. PubMed ID: 15577131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adjuvant chemotherapy in primary carcinoma of the breast].
    Harbeck N
    Zentralbl Gynakol; 2003 Sep; 125(9):322-6. PubMed ID: 14569511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update: NCCN breast cancer Clinical Practice Guidelines.
    Carlson RW; McCormick B
    J Natl Compr Canc Netw; 2005 Nov; 3 Suppl 1():S7-11. PubMed ID: 16280118
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
    Ortmann O; Cufer T; Dixon JM; Maass N; Marchetti P; Pagani O; Pronzato P; Semiglazov V; Spano JP; Vrdoljak E; Wildiers H
    Breast; 2009 Feb; 18(1):2-7. PubMed ID: 19036588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aromatase inhibitors in the adjuvant therapy of breast cancer].
    Bauerschlag D; Schem C; Maass N; Jonat W
    Gynakol Geburtshilfliche Rundsch; 2005 Jun; 45(3):132-6. PubMed ID: 15990437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
    J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving treatment approaches for early breast cancer.
    Campos SM
    Breast Cancer Res Treat; 2005; 89 Suppl 1():S1-7. PubMed ID: 15770534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of goserelin in the treatment of breast cancer.
    Rody A; Loibl S; von Minckwitz G; Kaufmann M
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):591-604. PubMed ID: 16111461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
    Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
    J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of ovarian ablation in the management of breast cancer.
    Wirk B
    Breast J; 2005; 11(6):416-24. PubMed ID: 16297086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ.
    Vogel VG; Costantino JP; Wickerham DL; Cronin WM
    Clin Cancer Res; 2003 Jan; 9(1 Pt 2):495S-501S. PubMed ID: 12538506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.